No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant

Clinical Transplantation, EarlyView.

Source: Clinical Transplantation - April 20, 2018 Category: Transplant Surgery Authors: Sanjaya K. Satapathy , Kanak Das , Mehmet Kocak , Ryan A. Helmick , James D. Eason , Satheesh P. Nair , Jason M. Vanatta Source Type: research